Haemonetics (HAE) Other Non Operating Income (2009 - 2026)

Haemonetics' Other Non Operating Income history runs 18 years deep, the most recent figure standing at -$5.4 million for Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 798.66% year-over-year to -$5.4 million in Q1 2026; TTM through Mar 2026 was -$28.7 million, a 194.52% decrease from a year earlier, with the FY2026 full-year figure at -$28.7 million, down 194.52% from the prior year.
• Other Non Operating Income rose to -$5.4 million in Q1 2026 per HAE's latest filing, from -$7.4 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $7.0 million in Q2 2024 and bottomed at -$9.1 million in Q4 2024.
• The 5-year median for Other Non Operating Income is -$4.8 million (2022), against an average of -$4.1 million.
• Across the five-year window, Other Non Operating Income soared 436.25% in 2024 and plunged 798.66% in 2026, its largest moves.
• Year by year, Other Non Operating Income stood at -$1.1 million in 2022, then tumbled by 84.74% to -$1.9 million in 2023, then slumped by 367.52% to -$9.1 million in 2024, then advanced by 18.56% to -$7.4 million in 2025, then climbed by 27.58% to -$5.4 million in 2026.
• Per Business Quant, the three latest HAE Other Non Operating Income figures stand at -$5.4 million (Q1 2026), -$7.4 million (Q4 2025), and -$7.2 million (Q3 2025).